Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Božena Coha

3804

Božena

Coha

mr. sc.

nije evidentirano
Naziv Akcije
Krečak, Ivan ; Zekanović, Ivan ; Morić Perić, Martina ; Holik, Hrvoje ; Coha, Božena ; Periša, Vlatka ; Lucijanić, Marko High plateletcrit may be associated with thrombotic risk in polycythemia vera // International journal of laboratory hematology, (2023), doi: 10.1111/ijlh.14073
(KroHem) Sertić, Zrinka ; Lucijanić, Marko ; Bašić-Kinda, Sandra ; Serventi Seiwerth, Ranka ; Periša, Vlatka ; Sertić, Dubravka ; Coha, Božena ; Pulanić, Dražen ; Perić, Zinaida ; Desnica, Lana et al. Non-Myelofibrosis Chronic Myeloproliferative Neoplasm Patients Show Better Seroconversion Rates after SARS-CoV-2 Vaccination Compared to Other Hematologic Diseases: A Multicentric Prospective Study of KroHem // Biomedicines, 10 (2022), 11; 2892, 11. doi: 10.3390/biomedicines10112892
Krečak, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Zekanović, Ivan ; Coha, Božena ; Lucijanić, Marko Chronic Kidney Disease has a Higher Prevalence in Polycythemia Vera than in Secondary Polycythemia, a Matched Case–Control Analysis // Indian Journal of Hematology and Blood Transfusion, (2022), doi: 10.1007/s12288-022-01624-z
Galušić, Davor ; Bašić-Kinda, Sandra ; Pijuk, Anđela ; Milunović, Vibor ; Dreta, Barbara ; Franjić, Neven ; Coha, Božena ; Sinčić-Petričević, Jasminka ; Gaćina, Petar ; Pejša, Vlatko et al. Efficacy and Safety of Obinutuzumab-chemotherapy Combinations in Front-line Treatment of Follicular Non-Hodgkin Lymphoma During the COVID-19 Pandemic: A Study of KROHEM, the Croatian Cooperative Group for Hematologic Diseases // HemaSphere, 6 (2022), 12; e807, 6. doi: 10.1097/HS9.0000000000000807
Krečak, Ivan ; Holik, Hrvoje ; Zekanović, Ivan ; Morić Perić, Martina ; Marketin, Tina ; Coha, Božena ; Gverić-Krečak, Velka ; Vodanović, Marijo ; Lucijanić, Marko Thrombotic risk in secondary polycythemia resembles low-risk polycythemia vera and increases in specific subsets of patients // Thrombosis research, 209 (2022), 47-50. doi: 10.1016/j.thromres.2021.11.025
Krečak, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Zekanović, Ivan ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko Serum osmolarity in polycythemia vera and its clinical associations // International journal of laboratory hematology, Online ahead of (2022), 1-4. doi: 10.1111/ijlh.13844
Krečak, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Zekanović, Ivan ; Coha, Božena ; Gverić-Krečak, Velka ; Marko, Lucijanić High platelet-to-lymphocyte ratio may differentiate polycythemia vera from secondary polycythemia // Wiener klinische Wochenschrift, 134 (2022), 11-12; 483-486. doi: 10.1007/s00508-022-02027-w
Krečak, Ivan ; Holik, Hrvoje ; Coha, Božena ; Perić, Martina Morić ; Zekanović, Ivan ; Krečak, Marija Valovičić ; Gverić-Krečak, Velka ; Lucijanić, Marko Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera // Annals of hematology, 100 (2021), 5; 1335-1336. doi: 10.1007/s00277-021-04431-0
Krečak, Ivan ; Morić Perić, Martina ; Zekanović, Ivan ; Holik, Hrvoje ; Coha, Božena ; Gverić-Krečak, Velka ; Lucijanić, Marko No impact of the increased number of cardiovascular risk factors on thrombosis and survival in polycythemia vera // Oncology research and treatment, 44 (2021), 4; 201-203. doi: 10.1159/000514347
Krečak, Ivan ; Zekanović, Ivan ; Holik, Hrvoje ; Morić Perić, Martina ; Coha, Božena ; Gverić‐ Krečak, Velka Estimating plasma volume using the Strauss‐ derived formula may improve prognostication in polycythemia vera // International journal of laboratory hematology, Online ahead of (2021), https://doi.org/10.1111/ijlh.13716, 3. doi: 10.1111/ijlh.13716
nije evidentirano
nije evidentirano